Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Sally Hopewell

MSc, DPhil

Associate Professor

  • Theme Lead for Clinical Trials
  • University Research Lecturer

My key areas of research expertise are in the design, conduct and transparent reporting of randomized trials and systematic reviews. I have published a number of research studies in these areas including the development of key reporting guidelines such as the CONSORT Statement and PRISMA for Abstracts.

I joined OCTRU in February 2015, where I am involved in leading the design and delivery of clinical trials within the OCTRU portfolio. I am co-chief investigator on a large multicentre NIHR funded (£1.5m) trial of exercise interventions for people with rotator cuff disorders.

Previously, I worked at the Centre for Statistics in Medicine (2007 – 2015) on an MRC-funded programme of research related to CONSORT and the conduct and reporting of clinical trials. I also worked, and continue to collaborate with, the Centre d’Epidemiologie Clinique (2012 – present), University Paris Descartes, on research activities related to the methodology of systematic reviews and randomized trials.

Prior to this I worked at the UK Cochrane Centre (2004 – 2012) and with the NHS National Blood Service (2010 – 2012) systematic review programme. In 2005, I was awarded a D.Phil at the University of Oxford on research into the effects of unpublished data in systematic reviews.

I have a particular interest in clinical trial registration, data sharing, transparent reporting of clinical trial protocols, development of core outcome sets, pilot trials and trials of complex interventions. I am a Cochrane editor, associate editor for the journal Research Integrity and Peer Review, sit on the editorial board for the journal Systematic Reviews and am a member of the advisory board for Current Controlled Trials, NIHR Health Technology Assessment Clinical Evaluation and Trials Board and the IDEAL Collaboration. I regularly carry out peer review for high impact medical journals and various funding bodies (e.g. NIHR and Medical Research Council).